Ursula Vogel, PhD MBA

Ursula Vogel works with EspeRare in an advisory capacity for various development projects. She has over 25 years of global Biopharma industry experience, having started her career at Merck Sharp & Dohme and Sanofi, followed by a pivotal leadership role at pioneering US biotech Genetics Institute where she set up and managed the European affiliate until its acquisition by Wyeth (now Pfizer). She has been a major contributor to the success of 2 marketed products (Infuse®/InductOs, BeneFIX®). Since 2000 she has worked as an independent consultant helping conclude a multitude of licensing transactions and bring biopharmas to successful exits. Her main focus areas are Business & Corporate Development, and C-level or Board level representation.

She holds a PhD from Cambridge University, and an MBA from INSEAD.